Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?
Roberts
Patrick J
PJ
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7295, USA. patrick_roberts@unc.edu
Stinchcombe
Thomas E
TE
Der
Channing J
CJ
Socinski
Mark A
MA